Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Sieber

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Neural Transmission. Supplementum|January 1, 1990
Monoamine oxidase and the bioactivation of MPTP and related neurotoxins: relevance to DATATOPR E Heikkila, I Terleckyj, B A Sieber
Molecular and Chemical Neuropathology|June 1, 1989
Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouseR E Heikkila, B A Sieber, L Manzino, et al.
Neuroscience|August 23, 2005
Disruption of ephrin-A/EphA binding alters synaptogenesis and neural connectivity in the hippocampusA Martínez, R Otal, B-A Sieber, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administrationA Giovanni, B A Sieber, R E Heikkila, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1991
Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of miceA Giovanni, B A Sieber, R E Heikkila, et al.
Brain Research|June 5, 1992
Mesencephalic type I astrocytes mediate the survival of substantia nigra dopaminergic neurons in cultureE K O'Malley, B A Sieber, I B Black, et al.
Experimental Neurology|December 1, 1993
Regional and cell-specific expression of GDNF in rat brainD G Schaar, B A Sieber, C F Dreyfus, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1989
Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogsS K Youngster, P K Sonsalla, B A Sieber, et al.
Annals of the New York Academy of Sciences|May 11, 1992
Characteristics of dopaminergic neurotoxicity produced by MPTP and methamphetamineP K Sonsalla, A Giovanni, B A Sieber, et al.
Brain Research|May 30, 1994
Nigral type I astrocytes release a soluble factor that increases dopaminergic neuron survival through mechanisms distinct from basic fibroblast growth factorE K O'Malley, B A Sieber, R S Morrison, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Neural Transmission. Supplementum|January 1, 1990
Monoamine oxidase and the bioactivation of MPTP and related neurotoxins: relevance to DATATOPR E Heikkila, I Terleckyj, B A Sieber
Molecular and Chemical Neuropathology|June 1, 1989
Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouseR E Heikkila, B A Sieber, L Manzino, et al.
Neuroscience|August 23, 2005
Disruption of ephrin-A/EphA binding alters synaptogenesis and neural connectivity in the hippocampusA Martínez, R Otal, B-A Sieber, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1994
Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administrationA Giovanni, B A Sieber, R E Heikkila, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1991
Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of miceA Giovanni, B A Sieber, R E Heikkila, et al.
Brain Research|June 5, 1992
Mesencephalic type I astrocytes mediate the survival of substantia nigra dopaminergic neurons in cultureE K O'Malley, B A Sieber, I B Black, et al.
Experimental Neurology|December 1, 1993
Regional and cell-specific expression of GDNF in rat brainD G Schaar, B A Sieber, C F Dreyfus, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1989
Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogsS K Youngster, P K Sonsalla, B A Sieber, et al.
Annals of the New York Academy of Sciences|May 11, 1992
Characteristics of dopaminergic neurotoxicity produced by MPTP and methamphetamineP K Sonsalla, A Giovanni, B A Sieber, et al.
Brain Research|May 30, 1994
Nigral type I astrocytes release a soluble factor that increases dopaminergic neuron survival through mechanisms distinct from basic fibroblast growth factorE K O'Malley, B A Sieber, R S Morrison, et al.
Pageof 2